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Abstract
Up to now, there have been only a few reported cases of Mucosa-associated lymphoid tissue (MALT) lymphomas
arising in the rectum. Its clinical presentation is indistinguishable from that of rectal carcinoma but the treatment is
apparently different. Symptoms of primary lymphomas involving the rectum include; anorexia, weight loss, change
in bowel habits, obstruction, and bleeding. These symptoms are not disease specific and can be seen in many
other gastrointestinal disorders. Patients with polypoid masses may present with obstruction symptoms. In this rare
case, a female patient admitted to the emergency service with prolapsus of a rectal mass.
The optimal treatment of rectal MALT lymphoma is not well defined yet, given the rarity of the disease. Surgical
resection of the localized lesion and following adjuvant chemotherapy has proved to be an effective treatment
option. However, a close and long-lasting follow-up is important.
Introduction
Mucosa-associated lymphoid tissue (MALT) lymphoma
is an extranodal marginal zone B-cell neoplasm. MALT
lymphoma accounts for one case in twenty cases of lym-
phoma. Stomach is the most common site [1]. Its devel-
opment is thought to be closely associated with H.
pylori infection. Rectum is an uncommon site for
MALT lymphomas to develop, comprimising less than
one percent of all colorectal malignancies [2].
It remains still unclear, whether rectal MALT lym-
phoma is related to H. pylori infection or not. The opti-
mal treatment of rectal MALT lymphoma is not well
defined.
Therefore we decided to report here a 44-year-old
Turkish woman who admitted to the emergency service
with a mass, prolapsing from the anus and to discuss
the treatment options with a brief review of the
literature.
Case report
A 44-year-old Turkish woman admitted to the emer-
gency service on March 2007, with a mass, prolapsing
from the anus. After sedating the patient, we reducted
the mass back into the rectum. Routine laboratory
examination results were within normal ranges.
She had been smoking one packet of cigarette daily
for 15 years and was not addicted to alcohol. Her ana-
mnesis also revealed that; she couldn’t defecate without
digital help, since 6 months. Colonoscopy demonstrated
a 7 × 7 cm sized, round and well-defined mass; covered
with granular mucosa, at the lower rectum.
Histopathological examination of the biopsy specimens
from the rectal lesion demonstrated a low-grade B cell
lymphoma of MALT type (Extranodal marginal zone
lymphoma; diffuse lymphocytic infiltrate in the lamina
propria, with uniform membranous staining of the cells
with the B-cell marker CD20). CD5, CD10, CD23 and
bcl-6 markers were found negative. IgM and bcl-2 were
found positive. Histologic examination results of the
biopsy specimens from the rectal mucosa were negative
for H. pylori infection.
The urea breath test and serum H. pylori-IgG anti-
body were all negative. We did not palpate any superfi-
cial lymph node on physical examination. Pelvic
computed tomography (CT) showed an intrapelvic mass
in the rectum, measuring 7 × 6 × 6 cm.
Thoracal and upper abdominal CT scans and the
whole abdomen ultrasonography were reported as nor-
mal. Upper gastrointestinal endoscopy revealed normal
findings. Whole-body positron emission tomographic
scan and bone marrow biopsy had negative results for
the disease. The patient was diagnosed as having MALT
lymphoma. Her past history was unremarkable.
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The patient used to make digital interventions for
defecation and the mass could get out of the anus again
so we decided to make local resection of the mass
under general anesthesia. The mass was excised transan-
ally (Fig 1) (in pieces, because of friability); the tumor
measured 5 × 7 cm, localized 1-2 cm proximal to the
anal verge (Fig 2). After surgery, the patient received
adjuvant chemotherapy (cyclophosphamide, doxorubicin,
oncovin and prednisone).
Three months after the completion of therapy, a fol-
low-up colonoscopy revealed normal mucosal view. No
recurrence was detected with endoscopy and biopsies
during the 27-month follow up period.
Discussion
MALT lymphomas were first described in 1983 and
since then, they are being more frequently diagnosed as
a distinct clinical and pathological entity [3].
Extranodal marginal zone B-cell (MALT) lymphomas
account for approximately 7.6% of all the Non-Hodgkin
lymphomas; among which, they are the third most fre-
quent histologic subtype (after the diffuse large B-cell
lymphoma and the follicular lymphoma) [4]. It can be
seen at any age from early adulthood to older ages, but
is more common in people over the age 55. The disease
is slightly more common in women than in men. MALT
lymphoma is a low-grade lymphoma and often performs
a slow developmental course.
The origin of rectal MALT lymphomas, is unknown.
Many patients have a history of autoimmune disease
such as Sjögren’s syndrome or Hashimoto’s thyroiditis,
or bacterial infection of the stomach with Helicobacter
pylori; our patient had none of these [5-7].
H. pylori infection has an important role in the devel-
opment of gastric MALT lymphoma. The birth of
MALT lymphoma in the stomach is preceeded with the
onset of a mucosa-associated lymphoid tissue (MALT);
which generally develops as the result of chronic infec-
tion by H. pylori [8,9].
The eradication of H. pylori with combination therapy,
can be effectively used as the initial treatment of loca-
lized gastric MALT lymphoma. However, eradication
therapy is not effective in 20-40% of cases because an
AP12-MALT1 gene-positive case will not respond to
eradication therapy [10]. Molecular follow-up studies
revealed the persistence of the malignant clone in more
than 50% of the cases with histological remission, after
the antibiotic therapy. The clinical significance of this
data is still unclear. Transient and self-limiting histologi-
cal and molecular relapses can also happen. Therefore, a
long-term follow-up is mandatory for all the patients
who have received combination therapy for H. Pylori
eradication [11].
However there are only a few reported cases of MALT
lymphomas arising in the rectum. That is why the ther-
apy options are not as clear as gastric MALT
lymphomas.
Current therapeutic options for rectal MALT lympho-
mas include; surgical resection, endoscopic mucosal
resection (EMR), different chemotherapy protocols and
H. pylori eradication [12]. Antibiotics and surgery may
be effective for the limited stage, low-grade MALT lym-
phomas [13]. When the case is not a candidate for sur-
gery; systemic chemotherapy and radiotherapy are useful
alternatives [14].
In literature, some authors have given HP eradication
therapy regardless of HP positivity or negativity. Inoue
et al [15], Nakase et al [16] have reported regression of
MALT lymphoma of the rectum after H. Pylori eradica-
tion therapy; containing proton pump inhibitor, amoxi-
cillin, and clarithromycin in patients negative for H.
pylori infection. Grunberger et al. [17] examined the H.Figure 1 View of the mass on the operation table.
Figure 2 View of the resected mass.
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pylori-positivity rate among MALT lymphomas except
for primary gastric MALT lymphomas; and found the
H. pylori-positivity rate to be 45% (35 of 77 cases). Era-
dication therapy was applied to 16 H. pylori-positive
cases. Eradication therapy was effective for only one
case and there was no response at the remaining 15
cases.
Therefore, future studies on the efficacy of H. Pylori
eradication therapy for non-gastric MALT lymphomas
are warranted.
That is why we performed transanal local resection of
the mass under general anesthesia.
Rectal MALT lymphoma has not been well investi-
gated when compared to gastric MALT lymphoma. The
metastatic ability of the rectal MALT lymphoma and its
sensitivity to chemotherapy, is not known. For rectal
MALT lymphomas, literature suggests that local surgical
resection of the lesion may be the best choice [18]. For
our case, surgical resection of the localized lesion and
post-surgical adjuvant chemotherapy (cyclophospha-
mide, doxorubicin, oncovin and prednisone) were effec-
tive. Using a combination of surgery and adjuvant
chemotherapy; the 5-year survival rates have increased
from 27% to 55% [19]. Therefore, a long-term follow-up
is essential. Follow-up at the 27 th month has revealed
no evidence of tumor recurrence.
In summary; H. pylori infection may not have a role in
the development of rectal MALT lymphoma. This
patient has led us to the opinion that; in cases of loca-
lized rectal MALT lymphomas, the first step of treat-
ment should be surgical resection and the second step is
adjuvant chemotherapy. On the other hand, it is not
possible to make a eligible conclusion with one case; so
these patients should be followed-up for life, until more
precise knowledge.
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